相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conjugating Aptamer and Mitomycin C with Reductant-Responsive Linker Leading to Synergistically Enhanced Anticancer Effect
Qiuxia Yang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer
Jiaxuan He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles
Suping Li et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability
Shaoli Liu et al.
NANO LETTERS (2019)
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Suping Li et al.
NATURE BIOTECHNOLOGY (2018)
Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction
Quanwei Shi et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein
I-Ting Teng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Tissue Factor: A Conventional or Alternative Target in Cancer Therapy
Andreas Eisenreich et al.
CLINICAL CHEMISTRY (2016)
Soluble Tissue Factor in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation
Vladimir Y. Bogdanov et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth
Suping Li et al.
ONCOTARGET (2015)
Nucleic Acid Aptamer-Mediated Drug Delivery for Targeted Cancer Therapy
Huijie Zhu et al.
CHEMMEDCHEM (2015)
Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
Liyu Li et al.
BIOMATERIALS (2014)
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg et al.
INVESTIGATIONAL NEW DRUGS (2014)
Nanotechnological strategies for therapeutic targeting of tumor vasculature
Yanping Ding et al.
NANOMEDICINE (2013)
Strategies for advancing cancer nanomedicine
Vikash P. Chauhan et al.
NATURE MATERIALS (2013)
A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
E. Merit Reyes-Reyes et al.
CANCER RESEARCH (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Tissue Factor in Coagulation Which? Where? When?
Saulius Butenas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
Ralf Bieker et al.
BLOOD (2009)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Sridharan Soundararajan et al.
MOLECULAR PHARMACOLOGY (2009)
The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells
Sridharan Soundararajan et al.
CANCER RESEARCH (2008)
Discovery and development of anticancer aptamers
Christopher R. Ireson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties
X Huang et al.
BLOOD (2006)
Active tissue factor in blood?
S Butenas et al.
NATURE MEDICINE (2004)
Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation
A Dorfleutner et al.
BLOOD (2003)
分享论文
